Valanafusp Alfa

Names

[ CAS No. ]:
1815583-32-4

[ Name ]:
Valanafusp Alfa

Biological Activity

[Description]:

Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) [1].

[Related Catalog]:

Research Areas >> Metabolic Disease
Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Insulin Receptor

[In Vitro]

Valanafusp alfa (HIRMAb-IDUA) 与 HIR 胞外结构域 (ECD) 结合，EC50 为 0.93±0.07 nM[2]。 Valanafusp alfa (HIRMAb-IDUA) (0.3 μg/mL; 48 h) 与健康成纤维细胞相比，可使 Hurler 成纤维细胞中的糖氨基聚糖积累减少 70%[2]。

[In Vivo]

Valanafusp alfa (AGT-181) (0.2-20 mg/kg; IV) 慢性给药在所有剂量下都具有极好的安全性，并且对血浆或脑脊液的血糖控制没有影响[1]。 Valanafusp alfa (AGT-181) (0.2-20 mg/kg; IV) 在 Rhesus monkeys 体内稳定，清除率快，分布量大[1]。

[References]

[1]. Boado RJ, et al. AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys. J Biotechnol. 2009 Oct 26;144(2):135-41.  

[2]. Boado RJ, et al. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier. Biotechnol Bioeng. 2008 Feb 1;99(2):475-84.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.